Coronavirus disease (COVID-19) outbreak and phase 1 trials: should we consider a specific patient management?

The outbreak of the Coronavirus disease (COVID-19) pandemic has deeply challenged healthcare systems and care of patients with cancer. Phase 1 studies are among the most complicated clinical trials and require thorough patient selection, as well as intensive patient monitoring. In this perspective,...

Descripción completa

Detalles Bibliográficos
Autores principales: Postel-Vinay, Sophie, Massard, Christophe, Soria, Jean-Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Current Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383132/
https://www.ncbi.nlm.nih.gov/pubmed/32805640
http://dx.doi.org/10.1016/j.ejca.2020.07.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383132/
https://www.ncbi.nlm.nih.gov/pubmed/32805640
http://dx.doi.org/10.1016/j.ejca.2020.07.009

Ejemplares similares